{"id":66363,"date":"2020-09-01T18:01:21","date_gmt":"2020-09-01T18:01:21","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2722743"},"modified":"2020-09-01T18:01:21","modified_gmt":"2020-09-01T18:01:21","slug":"coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/","title":{"rendered":"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"180\" height=\"180\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p>The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success. They are ensuring quick development of new coronavirus vaccine as well as it is ready to distribute as soon as it&#8217;s approved. In the United States, the Biomedical Advanced Research and Development Authority (BARDA), a federal agency that funds disease-fighting technology, has recently announced that it invests billions to support coronavirus vaccine development and the scale-up of manufacturing for promising candidates.<\/p>\n<p>Latest Research Study on <strong>Global Coronavirus Vaccine Investment<\/strong> Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Coronavirus Vaccine Investment Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Coronavirus Vaccine Investment. This Report also covers the emerging player&rsquo;s data, including: competitive situation, sales, revenue and global market share of top manufacturers are Serum Institute of India (India), BioNTech SE (Germany), Pfizer Inc. (United States), Gilead Sciences Inc. (United States), GlaxoSmithKline (United States), Roche Holding AG (Switzerland), Inovio Pharmaceuticals, Inc. (United States), Moderna Inc. (United States), Novavax Inc. (United States) and AbbVie Inc. (United States).<\/p>\n<p><strong>Free Sample Report + All Related Graphs &amp; Charts @ : <a href=\"https:\/\/www.advancemarketanalytics.com\/sample-report\/129117-global-coronavirus-vaccine-investment-market\">https:\/\/www.advancemarketanalytics.com\/sample-report\/129117-global-coronavirus-vaccine-investment-market<\/a><br \/>\n<\/strong><br \/>\nMarket Drivers<\/p>\n<ul>\n<li>Increasing Number of People Affecting the Coronavirus Disease Worldwide<\/li>\n<li>Spread of Coronavirus Disease Worldwide<\/li>\n<li>Government Initiatives and Support for Vaccine Development<\/li>\n<\/ul>\n<p>Market Trend<\/p>\n<ul>\n<li>High Demand for Total Cure of Coronavirus Total Cure Treatment<\/li>\n<\/ul>\n<p>Restraints<\/p>\n<ul>\n<li>Unavailability of Government Approved Vaccines in the Market<\/li>\n<\/ul>\n<p>Opportunities<\/p>\n<ul>\n<li>Huge Investment by Major Players for Coronavirus Vaccine Development<\/li>\n<li>Rising Demand from End-users<\/li>\n<li>High Future Demand for Vaccine from the Market<\/li>\n<\/ul>\n<p>Challenges<\/p>\n<ul>\n<li>Huge Investment for Research and Development of Coronavirus Vaccine<\/li>\n<\/ul>\n<p><strong>Region Included are:<\/strong> North America, Europe, Asia Pacific, Oceania, South America, Middle East &amp; Africa<\/p>\n<p><strong>Country Level Break-Up:<\/strong> United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.<\/p>\n<p><strong>Enquire for customization in Report @: <a href=\"https:\/\/www.advancemarketanalytics.com\/enquiry-before-buy\/129117-global-coronavirus-vaccine-investment-market\">https:\/\/www.advancemarketanalytics.com\/enquiry-before-buy\/129117-global-coronavirus-vaccine-investment-market<\/a> <\/strong><\/p>\n<p><strong>Extracts from Table of Contents<br \/>\nChapter 1:<\/strong> Coronavirus Vaccine Investment Market Overview<strong><br \/>\nChapter 2:<\/strong> Global Coronavirus Vaccine Investment Market Share and Market Overview<strong><br \/>\nChapter 3:<\/strong> Coronavirus Vaccine Investment Market Manufacturers\/Players Analysis<strong><br \/>\n3.1<\/strong> Market Concentration Rate<strong><br \/>\n3.2<\/strong> Competition Scenario: BCG Matrix [Relative Market Share v\/s Revenue Growth Rate]<strong><br \/>\n3.3<\/strong> Heat Map Analysis<strong><br \/>\n3.4<\/strong> Comparative Market Share Analysis by Players (2018-2019) Rank, [% Market Share, Market Revenue]<strong><br \/>\n3.5<\/strong> Company Profile &#8211; Business Distribution by Region, Interview Record, Business Profile, Product\/Service Specification, Price, Revenue and Gross profit 2017-2019<br \/>\n<strong>3.6<\/strong> Price Benchmarking (2017-2019)<br \/>\n<strong>Chapter 4:<\/strong> Global Coronavirus Vaccine Investment Market Segmentation (Country Level Breakdown) (2014-2025)<\/p>\n<ul>\n<li>North America: United States, Canada, and Mexico.<\/li>\n<li>South &amp; Central America: Argentina, Chile, and Brazil.<\/li>\n<li>Middle East &amp; Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.<\/li>\n<li>Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands, Poland and Russia.<\/li>\n<li>Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.<\/li>\n<\/ul>\n<p><strong>Chapter 5:<\/strong> Global Coronavirus Vaccine Investment Market Breakdown by Segments (<em>by Type (Government, Private Firms), Application (Hospitals, Research Laboratories, Clinics, Others)<\/em>)<br \/>\n<strong>5.1<\/strong> Global Coronavirus Vaccine Investment Market Segmentation (Product Type) Market Size 2014-2025<br \/>\n<strong>5.2<\/strong> Different Coronavirus Vaccine Investment Price Analysis by Product Type (2014-2025)<br \/>\n<strong>5.3<\/strong> Global Coronavirus Vaccine Investment Market Segmentation (Product Type) Analysis<br \/>\n<strong>5.4<\/strong> Global Coronavirus Vaccine Investment Market by Application\/End users Market Size 2014-2025<br \/>\n<strong>5.5<\/strong> Global Coronavirus Vaccine Investment Market Segmentation (other segments) Analysis<br \/>\n<strong>Chapter 6:<\/strong> Methodology\/Research Approach, Data Source, Disclaimer<\/p>\n<p><strong><br \/>\nData Sources &amp; Methodology<\/strong><\/p>\n<p>The primary sources involves the industry experts from the Global Coronavirus Vaccine Investment Market including the management organizations, processing organizations, analytics service providers of the industry&rsquo;s value chain. All primary sources were interviewed to gather and authenticate qualitative &amp; quantitative information and determine the future prospects.<\/p>\n<p>In the extensive primary research process undertaken for this study, the primary sources &ndash; Postal Surveys, telephone, Online &amp; Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company&#8217;s Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.<br \/>\n<strong><br \/>\nGet More Information:<\/strong> <strong><a href=\"https:\/\/www.advancemarketanalytics.com\/reports\/129117-global-coronavirus-vaccine-investment-market\">https:\/\/www.advancemarketanalytics.com\/reports\/129117-global-coronavirus-vaccine-investment-market<\/a><br \/>\n<\/strong><br \/>\n<strong>What benefits does AMA research studies provides?<\/strong><\/p>\n<ul>\n<li>Supporting company financial and cash flow planning<\/li>\n<li>Latest industry influencing trends and development scenario<\/li>\n<li>Open up New Markets<\/li>\n<li>To Seize powerful market opportunities<\/li>\n<li>Key decision in planning and to further expand market share<\/li>\n<li>Identify Key Business Segments, Market proposition &amp; Gap Analysis<\/li>\n<li>Assisting in allocating marketing investments<\/li>\n<\/ul>\n<p>Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.<\/p>\n<p>Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-austria-market\/\" rel=\"tag\">Coronavirus Vaccine Investment Austria Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-europe-market\/\" rel=\"tag\">Coronavirus Vaccine Investment Europe Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-france-market\/\" rel=\"tag\">Coronavirus Vaccine Investment France Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-germany-market\/\" rel=\"tag\">Coronavirus Vaccine Investment Germany Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-market-covid-19-impact\/\" rel=\"tag\">Coronavirus Vaccine Investment Market covid 19 impact<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-spain-market\/\" rel=\"tag\">Coronavirus Vaccine Investment Spain Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/coronavirus-vaccine-investment-uk-market\/\" rel=\"tag\">Coronavirus Vaccine Investment Uk Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/covid-outbreak-coronavirus-vaccine-investment-market\/\" rel=\"tag\">Covid Outbreak Coronavirus Vaccine Investment Market<\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"http:\/\/www.advancemarketanalytics.com\" target=\"_blank\">http:\/\/www.advancemarketanalytics.com<\/a><br \/><b>Contact Information:<\/b><br \/>Contact US:<br \/>\nCraig Francis (PR &#038; Marketing Manager)<br \/>\nAMA Research &#038; Media LLP<br \/>\nUnit No. 429, Parsonage Road Edison, NJ<br \/>\nNew Jersey USA &ndash; 08837<br \/>\nPhone: +1 (206) 317 1218<br \/>\nsales@advancemarketanalytics.com<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn_internal_distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Contact US:<br \/>\nCraig Francis (PR &#038; Marketing Manager) <br \/>\nAMA Research &#038; Media LLP<br \/>\nUnit No. 429, Parsonage Road Edison, NJ <br \/>\nNew Jersey USA \u2013 08837 <br \/>\nPhone: +1 (206) 317 1218 <br \/>\nsales@advancemarketanalytics.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"180\" height=\"180\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\" alt=\"\">The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\">Continue reading <span>Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":124,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,67,4],"tags":[],"class_list":["post-66363","post","type-post","status-publish","format-standard","hentry","category-english","category-icn-internal-distribution","category-research-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business\" \/>\n<meta property=\"og:description\" content=\"The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars &hellip; Continue reading Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-01T18:01:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\" \/>\n<meta name=\"author\" content=\"Craigfrancis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Craigfrancis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\",\"name\":\"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\",\"datePublished\":\"2020-09-01T18:01:21+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/463704c5bf70cee91245ba0c84f3944b\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/463704c5bf70cee91245ba0c84f3944b\",\"name\":\"Craigfrancis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b23311f10ec7bed4c8cd4c7f889137d9d2c45fa22fd40b8bb550370d1c687148?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b23311f10ec7bed4c8cd4c7f889137d9d2c45fa22fd40b8bb550370d1c687148?s=96&d=mm&r=g\",\"caption\":\"Craigfrancis\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/craigfrancis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/","og_locale":"en_US","og_type":"article","og_title":"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business","og_description":"The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars &hellip; Continue reading Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/","og_site_name":"Business","article_published_time":"2020-09-01T18:01:21+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg","type":"","width":"","height":""}],"author":"Craigfrancis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Craigfrancis","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/","url":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/","name":"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg","datePublished":"2020-09-01T18:01:21+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/463704c5bf70cee91245ba0c84f3944b"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/09\/824-1598983282.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/09\/01\/coronavirus-vaccine-investment-market-next-big-thing-major-giants-moderna-novavax-abbvie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Coronavirus Vaccine Investment Market Next Big Thing | Major Giants Moderna, Novavax, AbbVie"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/463704c5bf70cee91245ba0c84f3944b","name":"Craigfrancis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b23311f10ec7bed4c8cd4c7f889137d9d2c45fa22fd40b8bb550370d1c687148?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b23311f10ec7bed4c8cd4c7f889137d9d2c45fa22fd40b8bb550370d1c687148?s=96&d=mm&r=g","caption":"Craigfrancis"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/craigfrancis\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/66363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/124"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=66363"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/66363\/revisions"}],"predecessor-version":[{"id":66364,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/66363\/revisions\/66364"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=66363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=66363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=66363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}